Clover Health Investments Corp reports results for the quarter ended September 30 - Earnings Summary

• Clover Health Investments Corp CLOV.OQ reported a quarterly adjusted loss of 10 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -2 cents. The mean expectation of three analysts for the quarter was for a loss of 10 cents per share. Wall Street expected results to range from -3 cents to -10 cents per share.

• Revenue rose 47.4% to $487.71 million from a year ago; analysts expected $471.09 million.

• Clover Health Investments Corp's reported EPS for the quarter was a loss of 10 cents​.

• The company reported a quarterly loss of $49.32 million.

• Clover Health Investments Corp shares had fallen by 11.1% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell." The average consensus recommendation for the managed healthcare peer group is "buy."

• Wall Street's median 12-month price target for Clover Health Investments Corp is $3.00, about 28.3% above its last closing price of $2.15

This summary was machine generated from LSEG data February 26 at 11:32 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)